Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:43 PM
Ignite Modification Date:
2025-12-24 @ 6:43 PM
NCT ID:
NCT00930657
Eligibility Criteria:
* INCLUSION CRITERIA:
* Children age 9-18, and young adults 18-20 who have a parent with a past or current history of PD.
EXCLUSION CRITERIA (ALL PARTICIPANTS):
* Serious, unstable illnesses including hepatic, renal, gastroenterologic, respiratory, cardiovascular, endocrinologic, neurologic, immunologic, or hematologic disease, one or more past seizures without a clear and resolved etiology,
* Subjects who are currently at high risk for homicide or suicide,
* Subjects with symptoms of psychosis
* Subjects with current DSM-IV substance abuse or dependence within the past year.
* Subjects with IQ\<70,
ADDITIONAL EXCLUSION CRITERIA FOR CHILDREN:
* mania,
* pervasive developmental disorder,
* use of psychotropic medication,
* Child participants must be psychotropic free for at least 14 days prior to the CO(2) challenge session.
* For children taking fluoxetine, they must be free of this medication for at least 4 weeks.
* The proband parent must be a legal guardian of the child to qualify for the study.
Offspring passing screening criteria will be scheduled for an intake to complete a clinical interview, questionnaires, and CO(2) challenge task with assessment of respiratory physiology.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
9 Years
Maximum Age:
20 Years
Study:
NCT00930657
Study Brief:
Protocol Section:
NCT00930657